<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412020000100002</article-id>
<article-id pub-id-type="doi">10.24245/gom.v88i1.3253</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Desempeño diagnóstico del modelo FullPIERS como predictor de complicaciones perinatales en pacientes con preeclampsia]]></article-title>
<article-title xml:lang="en"><![CDATA[Diagnostic performance of FullPIERS model as predictor of perinatal complications in patients with preeclampsia]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cazarez-Ávalos]]></surname>
<given-names><![CDATA[Ingrid América]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García-Benavente]]></surname>
<given-names><![CDATA[Demnsi]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Toledo-Lorenzo]]></surname>
<given-names><![CDATA[Cinthia Nallely]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valle-Leal]]></surname>
<given-names><![CDATA[Jaime Guadalupe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López-Valenzuela]]></surname>
<given-names><![CDATA[Diego Misael]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital General Regional 1 ]]></institution>
<addr-line><![CDATA[Ciudad Obregón Sonora]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital General Regional 1 ]]></institution>
<addr-line><![CDATA[Ciudad Obregón Sonora]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<volume>88</volume>
<numero>1</numero>
<fpage>1</fpage>
<lpage>7</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412020000100002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412020000100002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412020000100002&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  OBJETIVO: Determinar el desempeño diagnóstico del modelo FullPIERS como predictor de complicaciones perinatales en pacientes con preeclampsia atendidas en un hospital público del Noroeste de México.  MATERIALES Y MÉTODO: Estudio retrospectivo, para evaluación de una prueba diagnóstica, efectuado en pacientes con diagnóstico de preeclampsia atendidas en un hospital público de segundo nivel entre octubre de 2018 y febrero 2019. Criterios de inclusión: expedientes con datos suficientes para introducirlos en la calculadora FullPIERS (saturación de oxígeno, recuento de plaquetas, creatinina, aspartato, transaminasa y existencia o no de disnea). Criterios de exclusión: pacientes con diagnóstico previo de padecimientos hepáticos agudos, pulmonares o renales. Se comparó el porcentaje de riesgo al ingreso de cada paciente versus la cantidad de pacientes con y sin complicaciones. Se calcularon: sensibilidad, especificidad y valores predictivos del modelo.  RESULTADOS: Se estudiaron 100 expedientes de pacientes con preeclampsia: 11 con resultados positivos según la calculadora Full PIERS (más de 5% de riesgo), en 7 de 11 fue verdadero positivo. Para el modelo Full PIERS se obtuvieron: sensibilidad de 58.3% y especificidad de 95.5%, valor predictivo positivo de 59%, y valor predictivo negativo de 95% para la predicción de complicaciones de la preeclampsia, con área bajo la curva de 0.799.  CONCLUSIÓN: La calculadora FullPIERS es una herramienta útil para predecir complicaciones a corto plazo y poder indicar el tratamiento adecuado a cada paciente.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  OBJECTIVE: To determine the diagnostic performance of the FullPIERS model as a predictor of perinatal complications in patients with preeclampsia from a public hospital in Northwest Mexico.  MATERIALS AND METHODS:  Retrospective study, for the evaluation of a proper diagnosis, performed in patients with diagnosis of preeclampsia attended at a second-level public hospital between October 2018 and February 2019. Inclusion criteria: sufficient data to introduce them into the FullPIERS calculator (saturation of oxygen, platelet retreat, creatinine, aspartate, transaminases and the existence of dysnea). Exclusion criteria: patients with previous diagnosis of acute, pulmonary or renal liver diseases. It is compared to the percentage of the ingrowth risk of each patient versus the number of patients with complications. Calculated: sensitivity, specificity and predictive values of the model.  RESULTS: If 100 patients were studied with preeclampsia: 11 with positive results according to the Full PIERS calculator (over 5% risk), and 7 out of 11 were true. For the Full PIERS model, it was obtained: 58.3% sensitivity and 95.5% specificity, 59% positive predictive value, and 95% negative predictive value for the prediction of complications of preeclampsia, with a curve area of 0.799.  CONCLUSION: The FullPIERS calculator is a useful tool for predicting complications to cut and can indicate the appropriate treatment for each patient.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Embarazo]]></kwd>
<kwd lng="es"><![CDATA[preeclampsia]]></kwd>
<kwd lng="es"><![CDATA[complicaciones]]></kwd>
<kwd lng="es"><![CDATA[creatinina]]></kwd>
<kwd lng="es"><![CDATA[enfermedades renales]]></kwd>
<kwd lng="es"><![CDATA[FullPIERS]]></kwd>
<kwd lng="en"><![CDATA[Pregnancy]]></kwd>
<kwd lng="en"><![CDATA[Pre-Eclampsia]]></kwd>
<kwd lng="en"><![CDATA[Complications]]></kwd>
<kwd lng="en"><![CDATA[Creatinine]]></kwd>
<kwd lng="en"><![CDATA[Oxygen]]></kwd>
<kwd lng="en"><![CDATA[Kidney diseases, FullPIERS]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[WHO analysis of causes of maternal death: a systemic review]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2006</year>
<volume>367</volume>
<page-range>1066-74</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Say]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global causes of maternal death: a WHO systemic analysis]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2014</year>
<volume>2</volume>
<page-range>323-33</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Prevención, diagnóstico y tratamiento de la preeclampsia en segundo y tercer nivel de atención. Evidencias y Recomendaciones]]></article-title>
<source><![CDATA[Guía de Práctica Clínica]]></source>
<year>2017</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[IMSS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Akkermans]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predicting complications in pre-eclampsia: external validation of the fullPIERS model using the PETRA trial dataset]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>2014</year>
<volume>179</volume>
<page-range>58-62</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Von Dadelszen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2011</year>
<volume>377</volume>
<numero>9761</numero>
<issue>9761</issue>
<page-range>219-27</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Payne]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission]]></article-title>
<source><![CDATA[BJOG]]></source>
<year>2013</year>
<volume>120</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>113-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Srivastava]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PIERS calculator- predicting adverse maternal outcome in preeclampsia]]></article-title>
<source><![CDATA[Int J Reprod Contracept Obstet Gynecol]]></source>
<year>2017</year>
<volume>6</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1200-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kuklina]]></surname>
<given-names><![CDATA[EV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hypertensive disorders and severe obstetric morbidity in the United States]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2009</year>
<volume>113</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1299-306</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aplicación de la escala de factores de riesgo para complicaciones de preeclampsia]]></article-title>
<source><![CDATA[Rev Chil Obstet Ginecol]]></source>
<year>2017</year>
<volume>82</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>438-46</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ukah]]></surname>
<given-names><![CDATA[UV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[External validation of the fullPIERS model for predicting adverse maternal outcomes in pregnancy hypertension in low- and middle-income countries]]></article-title>
<source><![CDATA[Hypertension]]></source>
<year>2017</year>
<volume>69</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>705-11</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Almeida]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of fullPIERS model for prediction of adverse outcomes among women with severe pre-eclampsia]]></article-title>
<source><![CDATA[Int J Gynaecol Obstet]]></source>
<year>2017</year>
<volume>138</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>142-7</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
